Cannabis and Hemp Industry Investment News
The 1,679,000 warrants were issued in the final week of May and were each exercised into one common company share at C$0.75 The warrants had been set ...
The maker of hard pill cannabinoid formulations said it can now fulfill the purchase order received from Australian hemp and medical cannabis group Ca...
Canntab Therapeutics (CSE: PILL- OTCQB: CTABF) CFO Richard Goldstein joined Steve Darling from Proactive with news the Australian Patent Office has gr...
In addition, the company has received an initial purchase order of $406,200 with its Australian partner, Cann Global Limited Cann Global will particip...
The company said it has now fulfilled 80% of the purchase amount contracted under the wholesale table purchase agreement entered into by the company a...
Only company in North America to have developed a product line of hard pills for a variety of cannabinoid and terpenoid blends Holds a Cannabis Standa...
Canntab Therapeutics (CSE: PILL- OTCQB: CTABF) CFO Richard Goldstein joined Steve Darling from Proactive with news the company, which has filed over a...
Canntab CEO Larry Latowsky told shareholders that the granting of the patent is another major milestone that confirms the group’s unique offering Cann...
Canntab Therapeutics closes C$1.575 million non-brokered private placement of convertible debentures
"We are pleased to have closed this offering so quickly and with only a few investors,” Canntab CEO Larry Lotowsky said in a statement The debentures ...
"We are pleased to have closed this offering so quickly and with only a few investors,” Canntab CEO Larry Lotowsky said in a statement The debentures ...
Canntab Therapeutics (CSE: PILL- OTCQB: CTABF) CEO Larry Latowski and CFO Richard Goldstein joined Steve Darling from Proactive with news the company ...
Canntab Therapeutics received purchase order from Australia while also taking part in research study
Canntab Therapeutics (CSE: PILL-OTCQB: CTABF) CFO Richard Goldstein joined Steve Darling from Proactive Vancouver with news the company has announced ...
The Canadian company will soon ship its suite of hard pill cannabinoid formulations to Australia, to be distributed by its partner CANN Global Through...
Canntab also closed a $300,000 deal with Pharmagenerics Solutions to purchase cannabis-processing equipment Canntab is focused on the manufacturing a...
Canntab Therapeutics (CSE: PILL-OTCQB: CTABF) CEO Larry Latowsky joined Steve Darling from Proactive Vancouver with news the company has secured prote...
The new patented tablets consist of both Instant Release and Extended Release formulations with THC and CBD as well as a variety of terpenes and other...
The company is offering more than 2.5 million shares in total at a price of C$0.51 per share Canntab is focused on the manufacturing and distribution ...
Canntab had originally announced that Latowsky would be appointed to the board as executive chairman, however, the board of directors unanimously dete...
What are you searching for? viewCanntab Therapeutics Ltd Canntab Therapeutics (CSE: PILL- OTCQB: CTABF) CFO Richard Goldstein and Special Advisor Larr...
Canntab said it was kicking off production of its instant release tablets today and already received its first order under the deal with MediPharm The...
